Thus, the objective of this study is to assess the performance of the four top-performing markers, MIF, OPN, PROL and CA-125 in detecting ovarian cancer patients from healthy controls in a retrospective study comprised of patients with both early and late-stage ovarian cancer. The gene discussed is MUC16; the disease is ovarian carcinoma.